Industry News
Alzheimer’s and the X factor
Study finds sex-specific risk SNP for late-onset Alzheimer’s [ + ]
Differentiating normal and cancer stem cells
Canadian researchers have demonstrated the difference between normal stem cells and cancer stem cells in humans. It is anticipated that this research will help scientists target cancer cells and leave healthy cells untouched during cancer treatment.
[ + ]New Year will be a second late
An extra second will be added to 2008 so that the world's clocks are in agreement with the Earth's rotation.
[ + ]Research grants boost national postgraduate numbers
The research in the university sector will be strengthened by the Rudd government's funding of an additional 1000 Australian Postgraduate Awards.
[ + ]Wales, papal mortality and the game they play in heaven
ALS on holidays, Benedict on medical alert due to leek threat [ + ]
Innovation opportunities with NSW eResearch Institute
The Institute for Transdisciplinary eResearch Services and Technology will facilitate e-research across NSW universities and relevant public and private sector research agencies. The NSW government is investing $2.8 million over three years to develop the institute.
[ + ]Strong research ties between Australia and France renewed
The potential for joint Australian–French science and research breakthroughs has been boosted with the signing of a memorandum of understanding between the two governments in Canberra.
[ + ]Fluorescent probes detect reactive oxygen species
Reactive oxygen species can be detected and measured in vivo using a new family of fluorescent probes called Hydrocyanines.
[ + ]Nominations open for Victoria's 2009 Premier's Award for Health and Medical Research
The Victorian government has committed over $2.1 billion to its Innovation Agenda and this includes $40,000 in prize money ($16,000 for the winner and $8000 each for three commended applicants) for the 2009 Premier’s Award for Health and Medical Research. Nominations for the award are now open.
[ + ]Parkinson’s indication for LCT
Rat studies show encapsulated brain cells useful in Parkinson’s model [ + ]
Arana begins Phase II
Multi-centre Phase II trial in rheumatoid arthritis begins [ + ]
HDIs and oncology’s great hope
Histone deacetylase inhibitors (HDIs) have emerged as oncology’s Great Hope – rarely has a new class of drugs showed promise against such a broad range of cancers, including leukaemias, lymphomas and solid tumours. [ + ]
Beer and a smoke: genetic link to alcohol tolerance
US researchers link genes for nicotine receptor to response to alcohol [ + ]
Head and neck for Viralytics
Viralytics finds fourth indication for oncolytic virus technology [ + ]
Promising results for CML
ChemGenex compound shows promising results in drug-resistant CML [ + ]
